Recipharm's sustainability strategy

At Recipharm, sustainability is embedded in how we operate and grow. To enable pragmatic and effective implementation, our strategy is built on a clear approach: measurable and challenging goals, clear roadmaps with defined milestones, and responsibility deeply anchored in the organisation. By integrating sustainability into our business model, we aim to drive long-term value, operational resilience and industry leadership in responsible pharmaceutical development and manufacturing.

We actively collaborate with customers to leverage sustainability as a strategic advantage, focusing on three levers: Products & Services (e.g.: transitioning to environmentally friendly materials and suppliers, reducing the use of critical solvents and environmentally toxic methods and reagents); Production (e.g.: optimising processes to reduce energy consumption and minimise waste); and Facility (e.g.: investing in sustainable infrastructure).

Our strategic direction is guided by three core principles.

Environmental leadership: we focus on minimising our footprint by integrating sustainable practices into product development, manufacturing and site operations. This includes: 

• Innovating for environmentally responsible pharmaceutical production, helping accelerate the transition to renewable energy in manufacturing. 
• Meeting and exceeding our targets validated by the SBTi, to reduce emissions and drive energy efficiency, ensuring long-term climate resilience and mitigating business risks.
• Advancing towards net-zero emissions by 2050, optimising resource efficiency in waste, water and energy use, and contributing to biodiversity preservation and healthier communities.

By embedding sustainability in our processes, we not only reduce our environmental impact but also strengthen our brand, gain competitive advantage and improve employee engagement, while supporting customers in their own sustainability journeys.

Social responsibility: sustainability is not just about the environment, it is also about people, patients and communities. We are committed to:

• Ensuring product quality and patient safety remain at the highest standards, reinforcing regulatory compliance and public health contributions.
• Fostering a diverse, inclusive and engaged workforce to drive innovation and performance, promoting ethical practices across the value chain.
• Embedding a strong safety culture across all sites to protect our employees, ensuring stable production and supply chain resilience.

Through these initiatives, we enhance employee safety and opportunities, while contributing to patient welfare, anti-discriminatory policies and ethical industry standards.

Strong governance and accountability: we operate within a comprehensive ESG governance framework. We achieve this through:

• Strong business ethics and speak up culture, upheld through our Code of Conduct, robust compliance framework and Whistleblowing Hotline, ensuring integrity and accountability across our business.
• Transparent reporting aligned with the CSR Directive, to meet evolving regulatory and stakeholder expectations, fostering ethical leadership and compliance.
• Upholding ethical business practices through our commitment to the UN Global Compact and industry best practices, strengthening stakeholder trust and engagement.

By ensuring strong governance, we proactively manage risks, drive strategic alignment, and reinforce our position as a responsible corporate leader.

Through a focus on innovation, accountability and collaboration, we position ourselves as a trusted partner in sustainability, helping to shape a more responsible pharmaceutical industry while delivering commercial value.